Further defining the commonalities and differences between GLP-1R agonists and bariatric surgery in terms of how they target the brain may not only help bridge the gap between pharmacological and surgical interventions for weight loss but also provide a neural basis for their combined use when each individually fails
Turkey (Skinless and Lean Cuts) Why Enjoy It : Turkey is a Thanksgiving staple and a lean protein source
Injection site reactions are relatively common, affecting anywhere from 0.5% to 40% of users
Some small studies, they note, have suggested that exercise can help improve VO 2 max for patients taking GLP-1 drugs, but these had poor controls and larger, well-designed studies are needed to bear that out
The article cites the SURMOUNT program showing 15 to 22 percent weight loss over 68 weeks for tirzepatide, against small non-randomized studies claiming roughly two to five pounds of monthly fat loss for lipotropic injections
Experimental evidence clearly demonstrates that GLP-1RAs such as liraglutide and semaglutide enhance AMPK activity, leading to increased expression of genes involved in mitochondrial fatty acid oxidation and diminished lipogenesis ( Concomitantly, GLP-1RAs suppress the expression of lipogenic transcription factors and enzymes, including sterol regulatory element-binding protein 1c (SREBP-1c) and fatty acid synthase (FAS), resulting in reduced de novo lipogenesis
